MENU
Anatomy
Anesthesiology
Biochemistry
Biomedical Informatics
Biophysics
Cell Biology
Clinical Cases
Dentistry
Dermatovenerology
Emergency Medicine
Family Medicine
Forensic Medicine
Gynecology and Obstetrics
Histology and Embryology
History of Medicine
Human Genetics
Hygiene
Infectious Diseases
Internal Medicine
Medical Deontology and Philosophy
Medical Psychology
Microbiology and Immunology
Neurology
Occupational Medicine
Oncology
Ophthalmology
Orthopaedics
Otorhinolaryngology
Pathology
Pathophysiology
Pediatrics
Pharmacology and Experimental Toxicology
Physical and Rehabilitation Medicine
Physiology
Psychiatry
Radiology
Social Medicine
Surgery
Toxicology
Research papers
Clinical research paper
Preclinical research paper
Sponsored articles
Archive » 1993 » 4 » | Archive » Medical field » Fields » Gynecology and Obstetrics » Archive » Medical field » Fields » Oncology »

Tumor marker CA 125 in gynecology

 
Abstract:

This post is also available in: enEnglish slSlovenščina (Slovenian)

The tumor marker CA 125 was detected in the sera of patients with epithelial ovarian cancer using high levels of labeled monoclonal antibodies. The paper lists the tissues in which CA 125 was found both in normal conditions and during tumor degeneration. Body fluids  which normally contain CA 125 levels are presented, as well as various factors responsible for elevated CA 125 levels in the serum, including physiological conditions, benign disorders and malignant diseases. The relationship between the tissue and serum CA 125 levels is explained. Clinical application of serum CA 125 assay to gynecologic diagnosis, disease monitoring and prognosis in ovarian cancer is described, as well as its potential use in patients with endometrial cancer and endometriosis. Finally, different CA 125 assays are presented, as well as the limitations of these methods.

Authors:
Antonič Jasmina

Keywords:
genital neoplasms female-diagnosis, tumor markers biological, CA 125 antigen

Cite as:
Med. Razgl. 1994; 32: 613–620.
© 2019 Društvo Medicinski razgledi | Na vrh strani / To top ↑